Return on Assets (ROA)
since 2005
Calculation
Illumina Inc., ROA, long-term trends, calculation
| ROA | = | 100 | × | Net income (loss) attributable to Illumina stockholders1 | ÷ | Total assets1 | |
|---|---|---|---|---|---|---|---|
| Dec 31, 2020 | 8.65% | = | 100 | × | 656) | ÷ | 7,585) |
| Dec 29, 2019 | 13.70% | = | 100 | × | 1,002) | ÷ | 7,316) |
| Dec 30, 2018 | 11.87% | = | 100 | × | 826) | ÷ | 6,959) |
| Dec 31, 2017 | 13.81% | = | 100 | × | 726) | ÷ | 5,257) |
| Jan 1, 2017 | 10.81% | = | 100 | × | 463) | ÷ | 4,281) |
| Jan 3, 2016 | 12.52% | = | 100 | × | 462) | ÷ | 3,688) |
| Dec 28, 2014 | 10.58% | = | 100 | × | 353) | ÷ | 3,340) |
| Dec 29, 2013 | 4.15% | = | 100 | × | 125) | ÷ | 3,019) |
| Dec 30, 2012 | 5.89% | = | 100 | × | 151) | ÷ | 2,566) |
| Jan 1, 2012 | 3.95% | = | 100 | × | 87) | ÷ | 2,196) |
| Jan 2, 2011 | 6.79% | = | 100 | × | 125) | ÷ | 1,839) |
| Jan 3, 2010 | 5.05% | = | 100 | × | 72) | ÷ | 1,430) |
| Dec 28, 2008 | 3.67% | = | 100 | × | 50) | ÷ | 1,377) |
| Dec 30, 2007 | -28.18% | = | 100 | × | (278) | ÷ | 988) |
| Dec 31, 2006 | 13.30% | = | 100 | × | 40) | ÷ | 301) |
| Jan 1, 2006 | -20.75% | = | 100 | × | (21) | ÷ | 101) |
Based on: 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-29), 10-K (reporting date: 2018-12-30), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2017-01-01), 10-K (reporting date: 2016-01-03), 10-K (reporting date: 2014-12-28), 10-K (reporting date: 2013-12-29), 10-K (reporting date: 2012-12-30), 10-K (reporting date: 2012-01-01), 10-K (reporting date: 2011-01-02), 10-K (reporting date: 2010-01-03), 10-K (reporting date: 2008-12-28), 10-K (reporting date: 2007-12-30), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2006-01-01).
1 US$ in millions
The analysis of the financial data reveals several notable trends over the examined periods. The net income attributable to Illumina stockholders exhibits significant volatility in the earlier years, including a substantial loss of $278 million at the end of 2007, followed by recovery and generally positive earnings from 2008 onward. Noteworthy growth in net income occurs from 2013 to 2019, peaking at $1,002 million in 2019, before declining to $656 million in 2020.
Total assets demonstrate a consistent upward trajectory throughout the entire period. Starting from $101 million in early 2006, total assets increase steadily and substantially, reaching $7,585 million by the end of 2020. This growth indicates ongoing investment and expansion within the company.
Return on assets (ROA) shows a pattern that closely correlates with net income trends. Early negative ROA values correspond to the net losses experienced, with a low of -28.18% in 2007. From 2008 onward, ROA becomes positive, reflecting improved profitability. ROA peaks intermittently, with high values around 13.8% in 2017 and 13.7% in 2019, demonstrating efficient use of assets during these years. However, a decline to 8.65% in 2020 signals a reduction in asset profitability despite the continued asset base growth.
- Net Income Trends
- Initial volatility with losses transitioning to sustained profitability from 2008 forward.
- Peak net income observed in 2019, with a subsequent decline in 2020.
- Total Assets Growth
- Consistent increase across all periods, indicating expansion and asset accumulation.
- More than 70-fold increase from 2006 to 2020.
- Return on Assets (ROA)
- ROA moves from negative to positive values, aligning with improved net income performance.
- Peaks in 2017 and 2019 illustrate periods of high operational efficiency.
- Decline in 2020 suggests challenges in maintaining asset profitability despite growth.
Comparison to Competitors
Illumina Inc., ROA, long-term trends, comparison to competitors
| Illumina Inc. | AbbVie Inc. | Amgen Inc. | Bristol-Myers Squibb Co. | Danaher Corp. | Eli Lilly & Co. | Gilead Sciences Inc. | Johnson & Johnson | Merck & Co. Inc. | Pfizer Inc. | Regeneron Pharmaceuticals Inc. | Thermo Fisher Scientific Inc. | Vertex Pharmaceuticals Inc. | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Dec 31, 2020 | 8.65% | 3.07% | 11.54% | -7.61% | 4.79% | 13.28% | 0.18% | 8.41% | 7.72% | 6.23% | 20.47% | 9.23% | 23.07% |
| Dec 29, 2019 | 13.70% | 8.84% | 13.13% | 2.65% | 4.85% | 21.17% | 8.74% | 9.59% | 11.66% | 9.72% | 14.29% | 6.33% | 14.15% |
| Dec 30, 2018 | 11.87% | 9.58% | 12.64% | 14.06% | 5.54% | 7.36% | 8.57% | 10.00% | 7.53% | 7.00% | 20.83% | 5.22% | 33.57% |
| Dec 31, 2017 | 13.81% | 7.50% | 2.48% | 3.00% | 5.34% | -0.45% | 6.58% | 0.83% | 2.72% | 12.40% | 13.67% | 3.93% | 7.43% |
| Jan 1, 2017 | 10.81% | 9.01% | 9.95% | 13.22% | 5.64% | 7.05% | 23.70% | 11.71% | 4.11% | 4.20% | 12.84% | 4.40% | -3.87% |
| Jan 3, 2016 | 12.52% | 9.70% | 9.69% | 4.93% | 6.96% | 6.77% | 34.93% | 11.55% | 4.36% | 4.16% | 11.34% | 4.83% | -22.26% |
| Dec 28, 2014 | 10.58% | 6.44% | 7.47% | 5.94% | 7.02% | 6.43% | 34.91% | 12.45% | 12.12% | 5.40% | 8.99% | 4.42% | -31.63% |
| Dec 29, 2013 | 4.15% | 14.14% | 7.68% | 6.64% | 7.77% | 13.29% | 13.67% | 10.42% | 4.17% | 12.78% | 14.38% | 4.00% | -19.19% |
| Dec 30, 2012 | 5.89% | 19.53% | 8.00% | 5.46% | 7.26% | 11.89% | 12.20% | 8.94% | 5.81% | 7.84% | 36.06% | 4.29% | -3.88% |
| Jan 1, 2012 | 3.95% | — | 7.54% | 11.25% | 7.25% | 12.92% | 16.20% | 8.51% | 5.97% | 5.32% | -16.75% | 4.96% | 1.34% |
| Jan 2, 2011 | 6.79% | — | 10.64% | 9.98% | 8.07% | 16.35% | 25.03% | 12.96% | 0.81% | 4.23% | -9.59% | 4.85% | -43.74% |
| Jan 3, 2010 | 5.05% | — | 11.62% | 34.22% | 5.88% | 15.76% | 27.18% | 12.95% | 11.51% | 4.05% | -9.15% | 3.93% | -32.84% |
| Dec 28, 2008 | 3.67% | — | 11.51% | 17.76% | 7.53% | -7.09% | 28.65% | 15.25% | 16.54% | 7.29% | -12.34% | 4.71% | -46.90% |
| Dec 30, 2007 | -28.18% | — | 9.14% | 8.27% | 7.84% | 11.02% | 27.68% | 13.06% | 6.77% | 7.07% | -11.28% | 3.59% | -65.05% |
| Dec 31, 2006 | 13.30% | — | 8.73% | 6.20% | 8.72% | 12.13% | -29.12% | 15.67% | 9.95% | 16.84% | -17.49% | 0.79% | -22.45% |
| Jan 1, 2006 | -20.75% | — | 12.54% | 10.66% | 9.80% | 8.05% | 21.62% | 17.94% | 10.33% | 6.88% | -22.54% | 5.25% | -37.05% |
Based on: 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-29), 10-K (reporting date: 2018-12-30), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2017-01-01), 10-K (reporting date: 2016-01-03), 10-K (reporting date: 2014-12-28), 10-K (reporting date: 2013-12-29), 10-K (reporting date: 2012-12-30), 10-K (reporting date: 2012-01-01), 10-K (reporting date: 2011-01-02), 10-K (reporting date: 2010-01-03), 10-K (reporting date: 2008-12-28), 10-K (reporting date: 2007-12-30), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2006-01-01).
Comparison to Sector (Pharmaceuticals, Biotechnology & Life Sciences)
Illumina Inc., ROA, long-term trends, comparison to sector (pharmaceuticals, biotechnology & life sciences)
| Illumina Inc. | Pharmaceuticals, Biotechnology & Life Sciences | |
|---|---|---|
| Dec 31, 2020 | 8.65% | 5.45% |
| Dec 29, 2019 | 13.70% | 9.02% |
| Dec 30, 2018 | 11.87% | 8.97% |
| Dec 31, 2017 | 13.81% | 5.28% |
| Jan 1, 2017 | 10.81% | 8.61% |
| Jan 3, 2016 | 12.52% | 8.93% |
| Dec 28, 2014 | 10.58% | 9.45% |
| Dec 29, 2013 | 4.15% | 9.46% |
| Dec 30, 2012 | 5.89% | 8.30% |
| Jan 1, 2012 | 3.95% | 7.30% |
| Jan 2, 2011 | 6.79% | 7.07% |
| Jan 3, 2010 | 5.05% | 10.02% |
| Dec 28, 2008 | 3.67% | 10.37% |
| Dec 30, 2007 | -28.18% | 8.86% |
| Dec 31, 2006 | 13.30% | 11.91% |
| Jan 1, 2006 | -20.75% | 10.42% |
Based on: 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-29), 10-K (reporting date: 2018-12-30), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2017-01-01), 10-K (reporting date: 2016-01-03), 10-K (reporting date: 2014-12-28), 10-K (reporting date: 2013-12-29), 10-K (reporting date: 2012-12-30), 10-K (reporting date: 2012-01-01), 10-K (reporting date: 2011-01-02), 10-K (reporting date: 2010-01-03), 10-K (reporting date: 2008-12-28), 10-K (reporting date: 2007-12-30), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2006-01-01).
Comparison to Industry (Health Care)
Illumina Inc., ROA, long-term trends, comparison to industry (health care)
| Illumina Inc. | Health Care | |
|---|---|---|
| Dec 31, 2020 | 8.65% | 5.45% |
| Dec 29, 2019 | 13.70% | 7.57% |
| Dec 30, 2018 | 11.87% | 6.72% |
| Dec 31, 2017 | 13.81% | 5.31% |
| Jan 1, 2017 | 10.81% | 7.18% |
| Jan 3, 2016 | 12.52% | 7.54% |
| Dec 28, 2014 | 10.58% | 8.41% |
| Dec 29, 2013 | 4.15% | 8.58% |
| Dec 30, 2012 | 5.89% | 7.94% |
| Jan 1, 2012 | 3.95% | 7.22% |
| Jan 2, 2011 | 6.79% | 7.11% |
| Jan 3, 2010 | 5.05% | 9.45% |
| Dec 28, 2008 | 3.67% | 9.08% |
| Dec 30, 2007 | -28.18% | 8.51% |
| Dec 31, 2006 | 13.30% | 10.37% |
| Jan 1, 2006 | -20.75% | 9.62% |
Based on: 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-29), 10-K (reporting date: 2018-12-30), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2017-01-01), 10-K (reporting date: 2016-01-03), 10-K (reporting date: 2014-12-28), 10-K (reporting date: 2013-12-29), 10-K (reporting date: 2012-12-30), 10-K (reporting date: 2012-01-01), 10-K (reporting date: 2011-01-02), 10-K (reporting date: 2010-01-03), 10-K (reporting date: 2008-12-28), 10-K (reporting date: 2007-12-30), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2006-01-01).